Loading…

Cross‐Priming is Under Control of the relB Gene

Cross‐priming is an important mechanism of intercell transfer of antigenic material leading to the specific activation of cytotoxic T lymphocytes. Dendritic cells (DCs) are considered the central antigen‐presenting cell in cross‐priming. Here we decided to probe the role of the relB gene, a regulato...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of immunology 2002-09, Vol.56 (3), p.219-223
Main Authors: CASTIGLIONI, P., JANSSEN, E. M., PRILLIMAN, K. R., GERLONI, M., SCHOENBERGER, S., ZANETTI, M.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cross‐priming is an important mechanism of intercell transfer of antigenic material leading to the specific activation of cytotoxic T lymphocytes. Dendritic cells (DCs) are considered the central antigen‐presenting cell in cross‐priming. Here we decided to probe the role of the relB gene, a regulator of DC differentiation, in the in vivo cross‐priming of a model tumour antigen, TAP(–/–) murine embryo cells (MEC), expressing human adenovirus type 5 early region 1. To this end, we used relB(–/–) mutant mice to generate bone marrow (BM) chimeras as these possess few residual DC but are capable of initiating CD4+ and CD8+ T‐cell responses in vivo. Our results show that relB(–/–) BM chimeras are unable to cross‐prime CD8+ T cells, suggesting that the relB gene regulates cross‐priming.
ISSN:0300-9475
1365-3083
DOI:10.1046/j.1365-3083.2002.01144.x